ABOUT THE SPEAKER
Nina Tandon - Tissue engineering researcher
Nina Tandon studies ways to use electrical signals to grow artificial tissues for transplants and other therapies.

Why you should listen

Nina Tandon studies electrical signaling in the context of tissue engineering, with the goal of creating “spare parts” for human implantation and/or disease models. After receiving a bachelor’s degree in electrical engineering from Cooper Union, Nina worked on an electronic nose used to “smell” lung cancer as a Fulbright scholar in Rome. She studied electrical stimulation for cardiac tissue engineering at MIT and Columbia, and now continues her research on electrical stimulation for broader tissue-engineering applications. Tandon was a 2011 TED Fellow and a 2012 Senior Fellow. Nina was also honored as one of Foreign Policy's 2015 Global Thinkers

More profile about the speaker
Nina Tandon | Speaker | TED.com
TEDGlobal 2012

Nina Tandon: Could tissue engineering mean personalized medicine?

Filmed:
1,204,216 views

Each of our bodies is utterly unique, which is a lovely thought until it comes to treating an illness -- when every body reacts differently, often unpredictably, to standard treatment. Tissue engineer Nina Tandon talks about a possible solution: Using pluripotent stem cells to make personalized models of organs on which to test new drugs and treatments, and storing them on computer chips. (Call it extremely personalized medicine.)
- Tissue engineering researcher
Nina Tandon studies ways to use electrical signals to grow artificial tissues for transplants and other therapies. Full bio

Double-click the English transcript below to play the video.

00:16
I'd like to show you a video of some of the models
0
843
2045
00:18
I work with.
1
2888
1589
00:20
They're all the perfect size, and they don't have an ounce of fat.
2
4477
3538
00:23
Did I mention they're gorgeous?
3
8015
2538
00:26
And they're scientific models? (Laughs)
4
10553
3130
00:29
As you might have guessed, I'm a tissue engineer,
5
13683
2343
00:31
and this is a video of some of the beating heart
6
16026
2449
00:34
that I've engineered in the lab.
7
18475
2216
00:36
And one day we hope that these tissues
8
20691
1882
00:38
can serve as replacement parts for the human body.
9
22573
2944
00:41
But what I'm going to tell you about today
10
25517
2280
00:43
is how these tissues make awesome models.
11
27797
4447
00:48
Well, let's think about the drug screening process for a moment.
12
32244
2727
00:50
You go from drug formulation, lab testing, animal testing,
13
34971
2978
00:53
and then clinical trials, which you might call human testing,
14
37949
2503
00:56
before the drugs get to market.
15
40452
2265
00:58
It costs a lot of money, a lot of time,
16
42717
3143
01:01
and sometimes, even when a drug hits the market,
17
45860
2810
01:04
it acts in an unpredictable way and actually hurts people.
18
48670
3935
01:08
And the later it fails, the worse the consequences.
19
52605
4087
01:12
It all boils down to two issues. One, humans are not rats,
20
56692
4184
01:16
and two, despite our incredible similarities to one another,
21
60876
4088
01:20
actually those tiny differences between you and I
22
64964
2441
01:23
have huge impacts with how we metabolize drugs
23
67405
2509
01:25
and how those drugs affect us.
24
69914
1869
01:27
So what if we had better models in the lab
25
71783
2832
01:30
that could not only mimic us better than rats
26
74615
3270
01:33
but also reflect our diversity?
27
77885
3920
01:37
Let's see how we can do it with tissue engineering.
28
81805
3927
01:41
One of the key technologies that's really important
29
85732
2529
01:44
is what's called induced pluripotent stem cells.
30
88261
3192
01:47
They were developed in Japan pretty recently.
31
91453
2518
01:49
Okay, induced pluripotent stem cells.
32
93971
2447
01:52
They're a lot like embryonic stem cells
33
96418
2113
01:54
except without the controversy.
34
98531
2217
01:56
We induce cells, okay, say, skin cells,
35
100748
2899
01:59
by adding a few genes to them, culturing them,
36
103647
2507
02:02
and then harvesting them.
37
106154
1621
02:03
So they're skin cells that can be tricked,
38
107775
2707
02:06
kind of like cellular amnesia, into an embryonic state.
39
110482
2784
02:09
So without the controversy, that's cool thing number one.
40
113266
2712
02:11
Cool thing number two, you can grow any type of tissue
41
115978
2549
02:14
out of them: brain, heart, liver, you get the picture,
42
118527
2555
02:16
but out of your cells.
43
121082
2523
02:19
So we can make a model of your heart, your brain
44
123605
3565
02:23
on a chip.
45
127170
2632
02:25
Generating tissues of predictable density and behavior
46
129802
2856
02:28
is the second piece, and will be really key towards
47
132658
2832
02:31
getting these models to be adopted for drug discovery.
48
135490
2672
02:34
And this is a schematic of a bioreactor we're developing in our lab
49
138162
3112
02:37
to help engineer tissues in a more modular, scalable way.
50
141274
3448
02:40
Going forward, imagine a massively parallel version of this
51
144722
3399
02:44
with thousands of pieces of human tissue.
52
148121
2337
02:46
It would be like having a clinical trial on a chip.
53
150458
4048
02:50
But another thing about these induced pluripotent stem cells
54
154506
3795
02:54
is that if we take some skin cells, let's say,
55
158301
2549
02:56
from people with a genetic disease
56
160850
2176
02:58
and we engineer tissues out of them,
57
163026
2256
03:01
we can actually use tissue-engineering techniques
58
165282
1968
03:03
to generate models of those diseases in the lab.
59
167250
3401
03:06
Here's an example from Kevin Eggan's lab at Harvard.
60
170651
3584
03:10
He generated neurons
61
174235
2290
03:12
from these induced pluripotent stem cells
62
176525
2715
03:15
from patients who have Lou Gehrig's Disease,
63
179240
2629
03:17
and he differentiated them into neurons, and what's amazing
64
181869
2443
03:20
is that these neurons also show symptoms of the disease.
65
184312
3152
03:23
So with disease models like these, we can fight back
66
187464
2099
03:25
faster than ever before and understand the disease better
67
189563
2582
03:28
than ever before, and maybe discover drugs even faster.
68
192145
3963
03:32
This is another example of patient-specific stem cells
69
196108
3380
03:35
that were engineered from someone with retinitis pigmentosa.
70
199488
4009
03:39
This is a degeneration of the retina.
71
203497
1754
03:41
It's a disease that runs in my family, and we really hope
72
205251
2757
03:43
that cells like these will help us find a cure.
73
208008
2224
03:46
So some people think that these models sound well and good,
74
210232
2808
03:48
but ask, "Well, are these really as good as the rat?"
75
213040
3441
03:52
The rat is an entire organism, after all,
76
216481
2988
03:55
with interacting networks of organs.
77
219469
1706
03:57
A drug for the heart can get metabolized in the liver,
78
221175
3921
04:00
and some of the byproducts may be stored in the fat.
79
225096
2840
04:03
Don't you miss all that with these tissue-engineered models?
80
227936
4527
04:08
Well, this is another trend in the field.
81
232463
2114
04:10
By combining tissue engineering techniques with microfluidics,
82
234577
2867
04:13
the field is actually evolving towards just that,
83
237444
2164
04:15
a model of the entire ecosystem of the body,
84
239608
2506
04:18
complete with multiple organ systems to be able to test
85
242114
2400
04:20
how a drug you might take for your blood pressure
86
244514
1603
04:22
might affect your liver or an antidepressant might affect your heart.
87
246117
3267
04:25
These systems are really hard to build, but we're just starting to be able to get there,
88
249384
4072
04:29
and so, watch out.
89
253456
3304
04:32
But that's not even all of it, because once a drug is approved,
90
256760
2632
04:35
tissue engineering techniques can actually help us develop more personalized treatments.
91
259392
3682
04:38
This is an example that you might care about someday,
92
263074
3742
04:42
and I hope you never do,
93
266816
2120
04:44
because imagine if you ever get that call
94
268936
2520
04:47
that gives you that bad news that you might have cancer.
95
271456
3208
04:50
Wouldn't you rather test to see if those cancer drugs
96
274664
2536
04:53
you're going to take are going to work on your cancer?
97
277200
2760
04:55
This is an example from Karen Burg's lab, where they're
98
279960
2422
04:58
using inkjet technologies to print breast cancer cells
99
282382
2906
05:01
and study its progressions and treatments.
100
285288
2471
05:03
And some of our colleagues at Tufts are mixing models
101
287759
2553
05:06
like these with tissue-engineered bone to see how cancer
102
290312
3088
05:09
might spread from one part of the body to the next,
103
293400
2720
05:12
and you can imagine those kinds of multi-tissue chips
104
296120
2384
05:14
to be the next generation of these kinds of studies.
105
298504
2985
05:17
And so thinking about the models that we've just discussed,
106
301489
2422
05:19
you can see, going forward, that tissue engineering
107
303911
1913
05:21
is actually poised to help revolutionize drug screening
108
305824
2456
05:24
at every single step of the path:
109
308280
2778
05:26
disease models making for better drug formulations,
110
311058
2574
05:29
massively parallel human tissue models helping to revolutionize lab testing,
111
313632
3871
05:33
reduce animal testing and human testing in clinical trials,
112
317503
4225
05:37
and individualized therapies that disrupt
113
321728
1692
05:39
what we even consider to be a market at all.
114
323420
3588
05:42
Essentially, we're dramatically speeding up that feedback
115
327008
2544
05:45
between developing a molecule and learning about
116
329552
2323
05:47
how it acts in the human body.
117
331875
2349
05:50
Our process for doing this is essentially transforming
118
334224
2328
05:52
biotechnology and pharmacology into an information technology,
119
336552
4861
05:57
helping us discover and evaluate drugs faster,
120
341413
2979
06:00
more cheaply and more effectively.
121
344392
3216
06:03
It gives new meaning to models against animal testing, doesn't it?
122
347608
4080
06:07
Thank you. (Applause)
123
351688
6815
Translated by Joseph Geni
Reviewed by Morton Bast

▲Back to top

ABOUT THE SPEAKER
Nina Tandon - Tissue engineering researcher
Nina Tandon studies ways to use electrical signals to grow artificial tissues for transplants and other therapies.

Why you should listen

Nina Tandon studies electrical signaling in the context of tissue engineering, with the goal of creating “spare parts” for human implantation and/or disease models. After receiving a bachelor’s degree in electrical engineering from Cooper Union, Nina worked on an electronic nose used to “smell” lung cancer as a Fulbright scholar in Rome. She studied electrical stimulation for cardiac tissue engineering at MIT and Columbia, and now continues her research on electrical stimulation for broader tissue-engineering applications. Tandon was a 2011 TED Fellow and a 2012 Senior Fellow. Nina was also honored as one of Foreign Policy's 2015 Global Thinkers

More profile about the speaker
Nina Tandon | Speaker | TED.com